Corbus Pharmaceuticals shares fall 2.92% after-hours after reporting a $17.7 million loss in Q2.

Corbus Pharmaceuticals Holdings, Inc. dropped 2.92% in after-hours trading, following the company's report of a $17.7 million loss in its second quarter, with a per-share loss of $1.44. Despite exceeding Wall Street expectations of a $1.55 per share loss, the overall financial performance was negative, leading to the stock's decline.